Charles M Baum's Net Worth
$42.3 Million
Who is Charles M Baum?
Charles M Baum has an estimated net worth of $42.3 Million. This is based on reported shares across multiple companies, which include IMMUNOMEDICS INC, PMV Pharmaceuticals, Inc., Mirati Therapeutics, Inc., BCTG Acquisition Corp., Poseida Therapeutics, Inc., ARRAY BIOPHARMA INC, and Acrivon Therapeutics, Inc..
SEC CIK
Charles M Baum's CIK is 0001579824
Past Insider Trading and Trends
2019 was Charles M Baum's most active year for acquiring shares with 13 total transactions. Charles M Baum's most active month to acquire stocks was the month of December. 2019 was Charles M Baum's most active year for disposing of shares, totalling 25 transactions. Charles M Baum's most active month to dispose stocks was the month of November. 2023 saw Charles M Baum paying a total of $1,999,998.00 for 167,018 shares, this is the most they've acquired in one year. In 2022 Charles M Baum cashed out on 157,938 shares for a total of $8,204,176.80, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNOMEDICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -9.67K |
—
|
—
|
0
|
Oct 23
| |||
Form 4
| +38.46% | 3.72K |
—
|
—
| 13.38K |
Jun 18
| |||
Form 4
|
∞
| 9.67K |
—
|
—
| 9.67K |
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.725
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mirati Therapeutics, Inc. (MRTX) No price found
Founder, President, and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -237.87K |
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +8.99% | 20.43K |
$58.75 | $1,199,968.75 | 247.7K |
Dec 29
| |||
Form 4
| +31.21% | 54.05K |
$37.00 | $1,999,998.00 | 227.28K |
Aug 9
| |||
Form 4
| +2.63% | 4.44K |
—
|
—
| 173.22K |
Jan 20
| |||
Form 4
| -2.12% | -3.65K |
$46.60 | -$169,996.80 | 168.78K |
Jan 4
| |||
Form 4
| +34.81% | 44.53K |
$40.42 | -$367,468.64 | 172.43K |
Dec 19 - Dec 21
| |||
Form 4
|
—
|
0
|
$58.71 | -$5,719,853.04 | 127.9K |
Scheduled
|
Nov 28
| ||
Form 4
| +26.42% | 26.73K |
$73.74 | -$203,272.45 | 127.9K |
Jan 14 - Jan 18
| |||
Form 4
| -3.91% | -4.11K |
$147.75 | -$607,854.71 | 101.17K |
Jan 4
| |||
Form 4
| -6.59% | -7.43K |
—
|
—
| 105.28K |
Dec 16
| |||
Form 4
|
—
|
0
|
$70.85 | -$5,886,925.50 | 112.71K |
Scheduled
|
Dec 3
| ||
Form 4
|
—
|
0
|
$86.98 | -$6,278,632.60 | 112.71K |
Scheduled
|
Jun 18
| ||
Form 4
| +2.08% | 2.29K |
$5.40 | $12,376.80 | 112.71K |
Jan 26
| |||
Form 4
| +26.18% | 22.91K |
$27.00 | $87,615.00 | 110.42K |
Jan 15 - Jan 19
| |||
Form 4
| -4.90% | -4.51K |
$210.39 | -$949,066.22 | 87.51K |
Jan 6
| |||
Form 4
| -9.80% | -10.00K |
—
|
—
| 92.02K |
Dec 29
| |||
Form 4
|
—
|
0
|
$121.49 | -$9,039,513.57 | 102.02K |
Scheduled
|
Dec 18
| ||
Form 4
| -4.67% | -5.00K |
—
|
—
| 102.02K |
Jul 23
| |||
Form 4
| +0.52% | 557 |
$5.40 | $3,007.80 | 107.02K |
Apr 27
| |||
Form 4
|
—
|
0
|
$49.41 | -$3,273,508.77 | 106.47K |
Scheduled
|
Apr 17
| ||
Form 4
| +2.20% | 2.29K |
$5.40 | $12,371.40 | 106.47K |
Mar 27
| |||
Form 4
| +2.25% | 2.29K |
$5.40 | $12,371.40 | 104.17K |
Feb 28
| |||
Form 4
| +4.82% | 4.69K |
$15.41 | $72,247.44 | 101.88K |
Feb 4
| |||
Form 4
| +69.93% | 40K |
—
|
—
| 97.2K |
Jan 3
| |||
Form 4
| +0.56% | 318 |
$24.93 | $7,927.23 | 56.92K |
Dec 24
| |||
Form 4
| -15.02% | -10.00K |
—
|
—
| 56.6K |
Dec 19
| |||
Form 4
| +0.84% | 558 |
$47.45 | -$4,013,021.44 | 66.6K |
Scheduled
|
Aug 22
| ||
Form 4
|
—
|
0
|
$42.09 | -$3,480,286.61 | 66.04K |
Scheduled
|
Feb 25
| ||
Form 4
| +5.80% | 3.62K |
$21.58 | $78,173.43 | 66.04K |
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
| +22.55% | 11.49K |
$33.84 | -$2,341,432.14 | 62.42K |
Scheduled
|
Aug 23 - Aug 24
| ||
Form 4
|
—
|
0
|
$18.37 | -$1,012,072.75 | 110.55K |
Scheduled
|
Feb 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
| +70.04% | 20K |
$7.05 | $141,070.00 | 48.56K |
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| +70.20% | 11.78K |
$8.49 | $99,995.22 | 28.56K |
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
| +235.56% | 11.78K |
$8.49 | $99,995.22 | 16.78K |
Feb 19
| |||
Form 4
|
∞
| 5K |
$16.96 | $84,819.00 | 5K |
Nov 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BCTG Acquisition Corp. (TNGX) Snapshot price: $12.73
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Poseida Therapeutics, Inc. (PSTX) Snapshot price: $3.79
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +50.00% | 19.65K |
—
|
—
| 58.95K |
Jun 15
| |||
Form 4
|
∞
| 39.3K |
—
|
—
| 39.3K |
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||